Arbutus Biopharma Corp (ABUS)

Stock-Based Compensation

$1.63M

Quarterly · Period ending: · USD

ABUS logo

ABUS Stock-Based Compensation

Latest reported$1.63M
ABUS Quarterly Stock-Based Comp ($0.00 → $1.63M)
High-resolution chart · PNG

ABUS stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
1,625,000
1,359,000
1,262,000
1,263,000
864,000
3,564,000
1,632,000
2,160,000
3,180,000
2,014,000
1,723,000
2,483,000
2,964,000
2,131,000
1,667,000
1,715,000
2,064,000
1,736,000
1,431,000
1,615,000
1,743,000
1,635,000
1,431,000
1,688,000
1,597,000
1,445,000
-23,000
1,516,000
3,784,000
1,522,000
796,000
1,828,000
2,661,000
955,000
1,532,000
3,979,000
5,103,000
4,503,000
4,681,000
4,454,000
22,111,000
7,912,000
7,360,000
7,503,000
5,423,000
2,934,000
569,000
445,000
1,081,000
1,188,000
440,599
219,539
110,283
132,192
510,018
142,906
147,405
179,058
252,085
183,043
87,182
90,929
143,452
108,286
45,807
352,969
37,789
46,998
81,162
87,784
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.